首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 4期 肝纤维化/肝硬化的可逆性及评价 => 肝纤维化及肝硬化 =>理气健脾方预防乙型肝..
理气健脾方预防乙型肝炎肝硬化合并重度食管胃底静脉曲张患者1年内出血的疗效评价
Clinical effect of Liqi Jianpi prescription in preventing hemorrhage within one year in patients with hepatitis B cirrhosis and severe esophageal and gastric varices
文章发布日期:2019年04月04日  来源:  作者:侯艺鑫,杨志云,杨玉英,等  点击次数:339次  下载次数:82次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的探究理气健脾方对乙型肝炎肝硬化合并重度食管胃底静脉曲张患者1年内出血风险的影响。方法选取2010年1月-2017年8月在北京地坛医院住院确诊为乙型肝炎肝硬化合并食管胃底静脉曲张重度的患者117例,分为治疗组(n=52)与对照组(n=65),2组患者均给予临床常规治疗,治疗组在此基础上加用理气健脾方汤剂口服。观察患者1年内上消化道出血发生率及治疗前后肝功能、胃镜检查、Child-Pugh分级情况。符合正态分布的计量资料组间比较采用t检验;不符合正态分布的计量资料组间比较采用Mann-Whitney U检验;计数资料组间比较采用χ2检验。结果治疗组1年内食管胃底静脉曲张破裂出血率为19.2%,对照组为38.5%,两组比较差异有统计学意义(χ2=4.112,P=0.038);治疗组治疗后的血清Alb水平与治疗前比较差异有统计学意义(t=0.934,P=0.037),与对照组治疗后比较,差异亦有统计学意义(t=2.928,P<0.05)。治疗组患者门静脉宽度治疗前为(14.1±2.7)mm,治疗后为(12.2±2.4)mm,治疗前后比较差异具有统计学意义(t=2.829,P=0.006);对照组患者门静脉宽度治疗前为(14.6±2.8)mm,治疗后为(14.3±2.5)mm,治疗前后比较差异无统计学意义(t=0.718,P=0.925);治疗组治疗后与对照组治疗后比较,门静脉宽度显著下降,差异具有统计学意义(t=1.715,P<0.05)。治疗组患者治疗前红色征患者20例,治疗后为9例,治疗前后比较差异具有统计学意义(χ2=0.884,P=0.008);治疗后,食管胃底静脉曲张程度较前缓解,重度患者由52例下降至38例,差异具有统计学意义(χ2=0.982,P=0.038)。结论理气健脾方可能具有降低乙型肝炎肝硬化合并食管胃底静脉曲张重度患者1年内上消化道出血发生率,改善患者肝功能,降低门静脉宽度,改善食管胃底静脉曲张程度的作用。
【Abstract】:ObjectiveTo investigate the effect of Liqi Jianpi prescription on the risk of hemorrhage within one year in patients with hepatitis B cirrhosis and severe esophageal and gastric varices. MethodsThe patients who were hospitalized in Beijing Ditan Hospital from January 2010 to August 2017 and were diagnosed with hepatitis B cirrhosis and esophageal and gastric varices were enrolled and divided into treatment group and control group. All patients were given conventional treatment, and the patients in the treatment group were given oral Liqi Jianpi decoction in addition to the conventional treatment. The incidence of upper gastrointestinal bleeding within one year was observed, and liver function, gastroscopy findings, and Child-Pugh class were observed before and after treatment. The t-test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. ResultsThere was a significant difference in the rate of esophagogastric variceal bleeding within one year between the treatment group and the control group (19.2% vs 38.5%, χ2=4.112, P=0.038). The treatment group had a significant change in serum albumin level after treatment (t=0.934, P<0.05), and there was a significant difference in serum albumin level between the two groups after treatment (t=2.928, P<0.05). In the treatment group, portal vein width decreased significantly from 14.1±2.7 mm before treatment to 12.2±2.4 mm after treatment (t=2829, P<0.01); in the control group, portal vein width was 14.6±2.8 mm before treatment and 14.3±2.5 mm after treatment (t=0718, P<0.05). After treatment, the treatment group had a significantly smaller portal vein width than the control group (t=1.715, P<0.05). In the treatment group, the number of patients with red color sign decreased significantly from 20 before treatment to 9 after treatment (χ2=0.884, P=0.08); after treatment, the degree of esophageal and gastric varices was alleviated, and the number of patients with severe varices decreased from 52 before treatment to 38 after treatment (χ2=0.982, P=0.038). ConclusionIn patients with hepatitis B cirrhosis and severe esophageal and gastric varices, Liqi Jianpi prescription can reduce the incidence rate of upper gastrointestinal bleeding within one year, improve liver function, reduce portal vein width, and improve the degree of esophageal and gastric varices.
【关键字】:肝炎, 乙型, 慢性; 肝硬化; 食管和胃静脉曲张; 胃肠出血; 理气健脾方; 治疗结果
【Key words】:hepatitis B, chronic; liver cirrhosis; esophageal and gastric varices; gastrointestinal hemorrhage; Liqi Jianpi Fang; treatment outcome
【引证本文】:HOU YX, YANG ZY, YANG YY, et al. Clinical effect of Liqi Jianpi prescription in preventing hemorrhage within one year in patients with hepatitis B cirrhosis and severe esophageal and gastric varices[J]. J Clin Hepatol, 2019, 35(4): 780-784. (in Chinese)
侯艺鑫, 杨志云, 杨玉英, 等. 理气健脾方预防乙型肝炎肝硬化合并重度食管胃底静脉曲张患者1年内出血的疗效评价[J]. 临床肝胆病杂志, 2019, 35(4): 780-784.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号